Study of LP-184 in Patients With Advanced Solid Tumors

Clinical trial NCT05933265 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05933265
Sponsor: Lantern Pharma Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor Metastatic Solid Tumor GBM TNBC - Triple-Negative Breast Cancer NSCLC Pancreatic Adenocarcinoma DDR Gene Mutation

Start date: 2023-06-09
Primary completion: 2026-07-28
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.